DiaMedica Therapeutics Inc.

Home » DiaMedica Therapeutics Inc.

IPO

DiaMedica Therapeutics Inc.

We are a clinical stage biopharmaceutical company primarily focused on the development of novel recombinant (synthetic) proteins. Our goal is to use our patented and licensed technologies to establish our company as a leader in the development and commercialization of novel recombinant proteins to treat neurological and kidney diseases.

Symbol

DMAC

Price Range
TBD

Anticipated Shares
TBD

Anticipated Date
TBD

Underwriters
Craig-Hallum Capital Group

To view the prospectus for DiaMedica Therapeutics Inc. IPO, or any offering listed on ClickIPO,
download the ClickIPO app...

or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC 8601 N Scottsdale Rd, Suite 335, Scottsdale, AZ 85253